发明名称 |
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING STRESS URINARY INCONTINENCE OR MIXED INCONTINENCE, AND METHOD FOR SCREENING COMPOUNDS TO BE INCLUDED IN SAID PHARMACEUTICAL COMPOSITION |
摘要 |
[Problem] To provide a pharmaceutical composition for treating or preventing urinary incontinence on the basis of a novel mechanism of action, and a method for screening a compound to be comprised in the pharmaceutical composition as an active ingredient. [Means for Solution] The present invention relates to a pharmaceutical composition for treating or preventing stress urinary incontinence or mixed urinary incontinence, comprising a compound having a melatonin receptor activation action as an active ingredient. Examples of the active ingredient include melatonin, ramelteon, agomelatine, tasimelteon, TIK-301, and the like. Further, the present invention relates to a method for screening a compound to be comprised in a pharmaceutical composition for treating or preventing stress urinary incontinence or mixed urinary incontinence as an active ingredient, consisting of a step of measuring a melatonin receptor activation, a step of measuring the contraction of the isolated urethra, a step of measuring the urethral pressure, and the like. |
申请公布号 |
EP2884275(A1) |
申请公布日期 |
2015.06.17 |
申请号 |
EP20130817263 |
申请日期 |
2013.07.09 |
申请人 |
ASTELLAS PHARMA INC. |
发明人 |
WATANABE, TORU;KAWABATA, KEIKO;WATANABE, YUKA;YUYAMA, HIRONORI;MASUDA, NORIYUKI;BURGARD, EDWARD C.;THOR, KARL BRUCE |
分类号 |
G01N33/15;A61K31/343;A61K31/381;A61K31/4045;A61K45/00;A61P7/12;A61P43/00;C12N15/09;C12Q1/02;G01N33/50 |
主分类号 |
G01N33/15 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|